Literature DB >> 33406810

Identification of Small Molecules Blocking the Pseudomonas aeruginosa type III Secretion System Protein PcrV.

Charlotta Sundin1, Michael Saleeb1, Sara Spjut1, Liena Qin1, Mikael Elofsson1.   

Abstract

Pseudomonas aeruginosa is an opportunistic bacterial pathogen that employs its type III secretion system (T3SS) during the acute phase of infection to translocate cytotoxins into the host cell cytoplasm to evade the immune system. The PcrV protein is located at the tip of the T3SS, facilitates the integration of pore-forming proteins into the eukaryotic cell membrane, and is required for translocation of cytotoxins into the host cell. In this study, we used surface plasmon resonance screening to identify small molecule binders of PcrV. A follow-up structure-activity relationship analysis resulted in PcrV binders that protect macrophages in a P. aeruginosa cell-based infection assay. Treatment of P. aeruginosa infections is challenging due to acquired, intrinsic, and adaptive resistance in addition to a broad arsenal of virulence systems such as the T3SS. Virulence blocking molecules targeting PcrV constitute valuable starting points for development of next generation antibacterials to treat infections caused by P. aeruginosa.

Entities:  

Keywords:  PcrV; Pseudomonas aeruginosa; infection; screening; surface plasmon resonance; type III secretion system; virulence inhibitors

Year:  2021        PMID: 33406810      PMCID: PMC7824769          DOI: 10.3390/biom11010055

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  51 in total

1.  Polarisation of type III translocation by Pseudomonas aeruginosa requires PcrG, PcrV and PopN.

Authors:  Charlotta Sundin; Johanna Thelaus; Jeanette E Bröms; Ake Forsberg
Journal:  Microb Pathog       Date:  2004-12-08       Impact factor: 3.738

2.  Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections.

Authors:  A Roy-Burman; R H Savel; S Racine; B L Swanson; N S Revadigar; J Fujimoto; T Sawa; D W Frank; J P Wiener-Kronish
Journal:  J Infect Dis       Date:  2001-05-17       Impact factor: 5.226

3.  Bispecific antibody targets multiple Pseudomonas aeruginosa evasion mechanisms in the lung vasculature.

Authors:  Ajitha Thanabalasuriar; Bas Gj Surewaard; Michelle E Willson; Arpan S Neupane; Charles K Stover; Paul Warrener; George Wilson; Ashley E Keller; Bret R Sellman; Antonio DiGiandomenico; Paul Kubes
Journal:  J Clin Invest       Date:  2017-05-02       Impact factor: 14.808

4.  The V antigen of Pseudomonas aeruginosa is required for assembly of the functional PopB/PopD translocation pore in host cell membranes.

Authors:  Julien Goure; Alexandrine Pastor; Eric Faudry; Jacqueline Chabert; Andréa Dessen; Ina Attree
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

5.  Characterization of the Binding of Hydroxyindole, Indoleacetic acid, and Morpholinoaniline to the Salmonella Type III Secretion System Proteins SipD and SipB.

Authors:  Andrew C McShan; Asokan Anbanandam; Sikta Patnaik; Roberto N De Guzman
Journal:  ChemMedChem       Date:  2016-03-18       Impact factor: 3.466

Review 6.  Protein secretion systems in Pseudomonas aeruginosa: A wealth of pathogenic weapons.

Authors:  Sophie Bleves; Véronique Viarre; Richard Salacha; Gérard P F Michel; Alain Filloux; Romé Voulhoux
Journal:  Int J Med Microbiol       Date:  2010-10-13       Impact factor: 3.473

7.  ChEMBL: a large-scale bioactivity database for drug discovery.

Authors:  Anna Gaulton; Louisa J Bellis; A Patricia Bento; Jon Chambers; Mark Davies; Anne Hersey; Yvonne Light; Shaun McGlinchey; David Michalovich; Bissan Al-Lazikani; John P Overington
Journal:  Nucleic Acids Res       Date:  2011-09-23       Impact factor: 16.971

8.  In the absence of effector proteins, the Pseudomonas aeruginosa type three secretion system needle tip complex contributes to lung injury and systemic inflammatory responses.

Authors:  Jonathon P Audia; Ashley S Lindsey; Nicole A Housley; Courtney R Ochoa; Chun Zhou; Michie Toba; Masahiko Oka; Naga S Annamdevula; Meshann S Fitzgerald; Dara W Frank; Diego F Alvarez
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

9.  Tanshinones: First-in-Class Inhibitors of the Biogenesis of the Type 3 Secretion System Needle of Pseudomonas aeruginosa for Antibiotic Therapy.

Authors:  Chao Feng; Yinong Huang; Wangxiao He; Xiyao Cheng; Huili Liu; Yongqi Huang; Bohan Ma; Wei Zhang; Chongbing Liao; Weihui Wu; Yongping Shao; Dan Xu; Zhengding Su; Wuyuan Lu
Journal:  ACS Cent Sci       Date:  2019-06-26       Impact factor: 14.553

10.  Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model.

Authors:  Karine Faure; Junichi Fujimoto; David W Shimabukuro; Temitayo Ajayi; Nobuaki Shime; Kiyoshi Moriyama; Edward G Spack; Jeanine P Wiener-Kronish; Teiji Sawa
Journal:  J Immune Based Ther Vaccines       Date:  2003-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.